ALX Africa, the innovative tech career accelerator, is thrilled to announce the enrollment of 30,000 new learners across Africa into its Artificial Intelligence Career Essentials (AiCE ...

ALX, Africa’s leading tech accelerator dedicated to fostering innovation and entrepreneurship, has received the Edtech Company of the Year award by the prestigious GAGE Awards. The recognition ...

Africa Renewal is a United Nations digital magazine that covers Africa’s economic, social and political developments. We cover the challenges the continent faces and the solutions to these by ...

Save the Children has worked in Africa for more than 60 years. Today, with millions of children and families in Africa already struggling to cope with the impacts of conflict and climate change, ...

ALX Oncology’s phase 2 gastric cancer response rate has weakened. After seeing its CD47 blocker easily beat control over the first half of the trial, the biotech reported a much closer fight in ...

Debating Ideas reflects the values and editorial ethos of the African Arguments book series, publishing engaged, often radical, scholarly, original and activist writing from within the African ...

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for ...

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on ALX Oncology Holdings (ALXO – Research Report), with a price target of $25.00. Swayampakula ...

Alexander’s (NYSE:ALX) just reported results for the second quarter of 2024. Alexander’s reported earnings per share of $3.31. This was above the analyst estimate for EPS of $2.67. The company ...

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept ...